Efficacy of palliative radiation therapy for symptomatic rectal cancer.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 27745911.
- Also identified by DOI 10.1016/j.radonc.2016.06.023.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
99 patients with symptomatic locally advanced rectal cancer who were treated with palliative radiation alone were reviewed. Dose-fractionation ranged from 18 to 54Gy. Response rate ranged from 62.5 to 86.7%, with a median response duration ranging 4.2-5.4months. Median survival was 6.9months. Using a BED cut-off of 39Gy<sub>10,</sub> no dose-response relationship was found.
Medical subject headings
- Palliative Care
- Rectal Neoplasms